Overview
- Targeted therapy determined by molecular genetics is emphasized
- Role of molecular genetics in the CNS cancer development is discussed
- Advantages and limitations of biomarkers in tumor detection and diagnosis are detailed
- The role of translational medicine is emphasized (bench to bed)
- Can be used as an outside reading to obtain additional information at seminars and conferences in the medical field
- Teachers in medicine would be interested
Part of the book series: Tumors of the Central Nervous System (TCNS, volume 1)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
Similar content being viewed by others
Keywords
Table of contents (42 chapters)
-
Introduction
-
Biomarkers and Diagnosis
Reviews
From the reviews:
“This is an outstanding book on every molecular mediator of cancer stem cells, angiogenesis, surface markers, and CAD mediators of oncogenesis in the brain. … This is a very good book for neuropathologists and neurosurgeons.” (Joseph J. Grenier, Amazon.com, June, 2014)Editors and Affiliations
Bibliographic Information
Book Title: Tumors of the Central Nervous System, Volume 1
Book Subtitle: Gliomas: Glioblastoma (Part 1)
Editors: M. A. Hayat
Series Title: Tumors of the Central Nervous System
DOI: https://doi.org/10.1007/978-94-007-0344-5
Publisher: Springer Dordrecht
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media B.V. 2011
Hardcover ISBN: 978-94-007-0343-8Published: 23 March 2011
Softcover ISBN: 978-94-007-3558-3Published: 23 April 2013
eBook ISBN: 978-94-007-0344-5Published: 23 March 2011
Series ISSN: 2215-096X
Series E-ISSN: 2215-0978
Edition Number: 1
Number of Pages: XXII, 434
Topics: Cancer Research, Neuroradiology, Neurosurgery, Oncology, Pathology, Surgery